Table 2.
Saturation grid: Decision attributes considered in CHC treatment decisions (n = 29)
| Decision Attribute | n | % |
|---|---|---|
| Physical side effects | 24 | 83 % |
| Efficacy/Cure rate | 23 | 79 % |
| New drugs in development | 16 | 55 % |
| Psychological/Mental health side effects | 16 | 55 % |
| Condition of liver | 15 | 52 % |
| Treatment regimen | 12 | 41 % |
| Support network/family help | 12 | 41 % |
| Other illnesses | 12 | 41 % |
| Quality of life | 11 | 38 % |
| Length of treatment | 9 | 31 % |
| Financial pressures/being able to work | 7 | 24 % |
| Age/life span | 7 | 24 % |
| Doctor’s recommendation | 7 | 24 % |
| Medical privacy/stigma | 7 | 24 % |
| Fear of transmitting illness | 6 | 21 % |
| Urgency to treat | 6 | 21 % |
| Trust in provider | 5 | 17 % |
| Travel to VHA | 5 | 17 % |
| Location/stability of living situation | 5 | 17 % |
| Caregiver responsibilities | 4 | 14 % |
| Quitting drinking/drugs | 4 | 14 % |
| Not wanting biopsy | 3 | 10 % |
| Other people’s experiences with treatment | 3 | 10 % |
| Using alternate/natural treatment/herbs | 3 | 10 % |